Basit öğe kaydını göster

dc.contributor.authorAvcu, Gulhadiye
dc.contributor.authorSensoy, Gulnar
dc.contributor.authorCeliksoy, Mehmet Halil
dc.contributor.authorSogut, Ayhan
dc.contributor.authorKefeli, Mehmet
dc.contributor.authorKarli, Arzu
dc.contributor.authorBelet, Nursen
dc.date.accessioned2020-06-21T13:50:57Z
dc.date.available2020-06-21T13:50:57Z
dc.date.issued2015
dc.identifier.issn1328-8067
dc.identifier.issn1442-200X
dc.identifier.urihttps://doi.org/10.1111/ped.12403
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14519
dc.descriptionWOS: 000350346800030en_US
dc.descriptionPubMed: 25711253en_US
dc.description.abstractLeukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/ped.12403en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectanti-tuberculosis drugen_US
dc.subjectethambutolen_US
dc.subjectleukocytoclastic vasculitisen_US
dc.subjectrifampicinen_US
dc.titleCutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume57en_US
dc.identifier.issue1en_US
dc.identifier.startpage155en_US
dc.identifier.endpage157en_US
dc.relation.journalPediatrics Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster